Insights

Dr Patil, from the University of Maryland School of Medicine, discusses the optimal and future uses of IL-12/23 inhibitors for the management of inflammatory bowel disease.

Dr Cheifetz, from Beth Israel Deaconess Medical Center in Boston, spoke about the treatment options available for patients with severe ulcerative colitis, from medical management to surgery at the recent Interdisciplinary Autoimmune Summit.

David Hudesman, MD, codirector of the IBD Center at NYU Langone Health, and Marla Dubinsky, MD, codirector of the Feinstein IBD Center at the Icahn School of Medicine at Mt Sinai, talk about the challenges of properly diagnosing and choosing...

Sunanda Kane, MD, from the Mayo Clinic and host Raymond Cross, MD, discuss JAK inhibitors in the treatment of inflammatory bowel disease in this IBD Drive Time.

In this podcast, Dr Edward Barnes discusses the highlights from his presentation on Immune Mediated Events Related To Medications from the Advances in Inflammatory Bowel Disease regional meeting September 25.

In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation on caring for the hospitalized patient with ulcerative colitis from the AIBD regional meeting on September 11.

In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, talks about the uses of the newest therapy approved for ulcerative colitis, S1P inhibitors, which he discussed at the AIBD regional meeting...

Dr Cross, director of the IBD Program at the University of Maryland, discusses factors to consider in using anti-integrins and anti-tumor necrosis factor therapeutics in managing inflammatory bowel disease.

In this video, Dr Horst, an associate professor and gastroenterologist at Vanderbilt University Medical Center in Nashville, Tennessee, discusses the risks of flares of inflammatory bowel disease following childbirth, and the safety of...